copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home - Arbutus Biopharma Just like our namesake Arbutus, a healing plant native to North America, we are leveraging our innovative portfolio of assets to focus our efforts on treating and curing conditions with unmet medical need
Partnering - Arbutus Biopharma At Arbutus, we are passionate about our mission and actively seeking collaborators and licensing opportunities within anti-viral diseases
HBV Assets - Arbutus Biopharma We take a three-pronged approach that combines compounds with complementary mechanisms of action to suppress viral antigens, reduce HBV DNA and boost the host immune system
About Arbutus - Arbutus Biopharma Arbutus is a plant found throughout North America, where we are headquartered, that is known to have healing properties Much like our botanical namesake, we are mutually focused on the growth of our portfolio of therapeutics and the healing of the patients who suffer from our targeted conditions
Pipeline - Arbutus Biopharma All Arbutus clinical trials are conducted in compliance with the Declaration of Helsinki and the ICH Guideline for Good Clinical Practice
Leadership Team - Arbutus Biopharma It takes a village to bring an asset to market At Arbutus, our village includes professionals with deep experience in drug development and commercialization
Imdusiran (AB-729) - Arbutus Biopharma AB-729 is a subcutaneously-delivered RNA interference (RNAi) therapeutic specifically designed to reduce all HBV viral antigens, including hepatitis B surface antigen (HBsAg)
Culture Careers - Arbutus Biopharma At Arbutus, we are always seeking exceptionally talented individuals who exemplify our values, share our entrepreneurial spirit, and thrive in a fast-paced science-driven environment
AB-101 - Arbutus Biopharma Our AB-101 oral inhibitor asset has been our longstanding strategy to combine compounds that reduce HBsAg, with agents that can further reawaken the immune system